Rare cancer study aims to unlock secrets of targeted therapy
NCT ID NCT07467317
First seen Mar 19, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study looks back at 100 people with a rare type of lymphoma (sALCL) who received a new targeted therapy combined with chemotherapy (BV-CHP). Researchers want to see how well the treatment works in real-world settings and understand why some patients respond better than others. They will analyze tumor samples and scans to find biological clues that predict treatment success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC LARGE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
A.O. Ordine Mauriziano - S.C.D.U. Ematologia
Torino, Italy
Contact Email: •••••@•••••
Contact
-
A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Avellino, Italy
Contact Email: •••••@•••••
Contact
-
A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia
Torino, Italy
Contact Email: •••••@•••••
Contact
-
A.S.L. di Pescara P.O. Santo Spirito - U.O.C. Ematologia
Pescara, Italy
Contact Email: •••••@•••••
Contact
-
A.S.S.T Papa Giovanni XXIII - S.C. Ematologia
Bergamo, Italy
Contact Email: •••••@•••••
Contact
-
A.S.S.T. Grande Ospedale Metropolitano Niguarda - S.C. Ematologia
Milan, Italy
Contact Email: •••••@•••••
Contact
-
A.S.S.T. Ovest Milanese Ospedale di Legnano - U.O.C. di Ematologia
Legnano, Italy
Contact Email: •••••@•••••
Contact
-
A.S.S.T. Sette Laghi - S.C. Ematologia
Varese, Italy
Contact Email: •••••@•••••
Contact
-
A.U.S.L. di Piacenza Osp. Guglielmo da Saliceto - U.O.C. Ematologia e Centro Trapianti
Piacenza, Italy
Contact Email: •••••@•••••
Contact
-
I.R.C.C.S. A.O.U. di Bologna Policlinico S. Orsola - U.O. Ematologia
Bologna, Italy
Contact Email: •••••@•••••
Contact
-
I.R.C.C.S. Centro di Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati
Aviano, Italy
Contact Email: •••••@•••••
Contact
-
I.R.C.C.S. Fondazione Policlinico Universitario Gemelli - U.O.S.D. Malattie linfoproliferative extramidollari
Roma, Italy
Contact Email: •••••@•••••
Contact
-
I.R.C.C.S. Istituto Europeo di Oncologia - U.O. Oncoematologia
Milan, Italy
Contact Email: •••••@•••••
Contact
-
I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia
Bari, Italy
Contact Email: •••••@•••••
Contact
-
I.R.C.C.S. Istituto di Candiolo - FPO
Candiolo, Italy
Contact Email: •••••@•••••
Contact
-
I.R.C.C.S. Ospedale San Raffaele - U.O. Ematologia e Trapianto di Midollo Osseo
Milan, Italy
Contact Email: •••••@•••••
Contact
-
IRCCS Humanitas Research Hospital - U.O. Ematologia
Rozzano, Italy
Contact Email: •••••@•••••
Contact
-
U.L.S.S. 2 Marca Trevigiana Osp. Ca' Foncello - U.O.C. Ematologia
Treviso, Italy
Contact Email: •••••@•••••
Contact
-
U.L.S.S. 8 Berica - U.O.C. Ematologia
Vicenza, Italy
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.